50 related articles for article (PubMed ID: 37706584)
1. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
[TBL] [Abstract][Full Text] [Related]
2. Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
Ruan D; Fang J; Teng X
Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):70-83. PubMed ID: 35420272
[TBL] [Abstract][Full Text] [Related]
3. Preoperative prediction of KRAS mutation status in colorectal cancer using a CT-based radiomics nomogram.
Xue T; Peng H; Chen Q; Li M; Duan S; Feng F
Br J Radiol; 2022 Jun; 95(1134):20211014. PubMed ID: 35312376
[TBL] [Abstract][Full Text] [Related]
4. Targeting
Uras IZ; Moll HP; Casanova E
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560574
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
[TBL] [Abstract][Full Text] [Related]
6. Identifying Robust Radiomics Features for Lung Cancer by Using In-Vivo and Phantom Lung Lesions.
Lu L; Sun SH; Afran A; Yang H; Lu ZF; So J; Schwartz LH; Zhao B
Tomography; 2021 Mar; 7(1):55-64. PubMed ID: 33681463
[TBL] [Abstract][Full Text] [Related]
7. Exploring Tumor Dissemination Characteristics and Prognostic Factors in Non-small Cell Lung Cancer: Insights From EGFR Mutations and PET/CT Radiomics.
Hsu CX; Yen SH
Acad Radiol; 2024 Mar; 31(3):1223-1224. PubMed ID: 37838524
[No Abstract] [Full Text] [Related]
8. Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Han X; Wang M; Zheng Y; Wang N; Wu Y; Ding C; Jia X; Yang R; Geng M; Chen Z; Zhang S; Zhang K; Li Y; Liu J; Gu J; Liao Y; Fan J; Shi H
Eur Radiol; 2024 Apr; 34(4):2716-2726. PubMed ID: 37736804
[TBL] [Abstract][Full Text] [Related]
9. Multi-channel multi-task deep learning for predicting
Dong Y; Hou L; Yang W; Han J; Wang J; Qiang Y; Zhao J; Hou J; Song K; Ma Y; Kazihise NGF; Cui Y; Yang X
Quant Imaging Med Surg; 2021 Jun; 11(6):2354-2375. PubMed ID: 34079707
[TBL] [Abstract][Full Text] [Related]
10. Integrating image and gene-data with a semi-supervised attention model for prediction of KRAS gene mutation status in non-small cell lung cancer.
Xue Y; Zhang D; Jia L; Yang W; Zhao J; Qiang Y; Wang L; Qiao Y; Yue H
PLoS One; 2024; 19(3):e0297331. PubMed ID: 38466735
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of machine learning in preoperative identification of genetic mutation status in lung cancer: A systematic review and meta-analysis.
Chen J; Chen A; Yang S; Liu J; Xie C; Jiang H
Radiother Oncol; 2024 May; 196():110325. PubMed ID: 38734145
[TBL] [Abstract][Full Text] [Related]
12. Habitat-Based Radiomics for Predicting EGFR Mutations in Exon 19 and 21 From Brain Metastasis.
Yang C; Fan Y; Zhao D; Wang Z; Wang X; Wang H; Hu Y; He L; Zhang J; Wang Y; Liu Y; Sha X; Su J
Acad Radiol; 2024 Apr; ():. PubMed ID: 38599906
[TBL] [Abstract][Full Text] [Related]
13. MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis.
Qi H; Hou Y; Zheng Z; Zheng M; Sun X; Xing L
Clin Radiol; 2024 Mar; ():. PubMed ID: 38637187
[TBL] [Abstract][Full Text] [Related]
14. Predicting epidermal growth factor receptor mutations in non-small cell lung cancer through dual-layer spectral CT: a prospective study.
Li F; Qi L; Cheng S; Liu J; Chen J; Cui S; Dong S; Wang J
Insights Imaging; 2024 Apr; 15(1):109. PubMed ID: 38679659
[TBL] [Abstract][Full Text] [Related]
15. Enhanced CT-based radiomics model to predict natural killer cell infiltration and clinical prognosis in non-small cell lung cancer.
Meng X; Xu H; Liang Y; Liang M; Song W; Zhou B; Shi J; Du M; Gao Y
Front Immunol; 2023; 14():1334886. PubMed ID: 38283362
[TBL] [Abstract][Full Text] [Related]
16. A biomarker basing on radiomics for the prediction of overall survival in non-small cell lung cancer patients.
He B; Zhao W; Pi JY; Han D; Jiang YM; Zhang ZG; Zhao W
Respir Res; 2018 Oct; 19(1):199. PubMed ID: 30305102
[TBL] [Abstract][Full Text] [Related]
17. Roles of EGFR and KRAS Mutations in the Treatment Of Patients With Non-Small-Cell Lung Cancer.
Langer CJ
P T; 2011 May; 36(5):263-79. PubMed ID: 21785539
[TBL] [Abstract][Full Text] [Related]
18. Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis.
Hu Y; Geng Y; Wang H; Chen H; Wang Z; Fu L; Huang B; Jiang W
J Comput Assist Tomogr; 2024 Mar; ():. PubMed ID: 38498926
[TBL] [Abstract][Full Text] [Related]
19. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives.
Chetan MR; Gleeson FV
Eur Radiol; 2021 Feb; 31(2):1049-1058. PubMed ID: 32809167
[TBL] [Abstract][Full Text] [Related]
20. Deep Learning to Predict EGFR Mutation and PD-L1 Expression Status in Non-Small-Cell Lung Cancer on Computed Tomography Images.
Wang C; Xu X; Shao J; Zhou K; Zhao K; He Y; Li J; Guo J; Yi Z; Li W
J Oncol; 2021; 2021():5499385. PubMed ID: 35003258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
